5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 109.77▼ | 110.06▼ | 110.13▼ | 112.05▼ | 110.11▼ |
MA10 | 110.05▼ | 110.28▼ | 111.58▼ | 111.68▼ | 107.99▲ |
MA20 | 110.13▼ | 111.82▼ | 112.37▼ | 110.05▼ | 108.21▲ |
MA50 | 110.26▼ | 112.30▼ | 112.01▼ | 107.48▲ | 96.39▲ |
MA100 | 111.43▼ | 112.00▼ | 110.07▼ | 108.38▲ | 85.16▲ |
MA200 | 112.37▼ | 109.93▼ | 110.12▼ | 99.74▲ | 78.52▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.059▼ | -0.217▼ | -0.471▼ | 0.115▲ | -0.315▼ |
RSI | 33.436▼ | 28.881▼ | 34.621▼ | 49.217▼ | 57.189▲ |
STOCH | 12.222▼ | 20.298 | 11.772▼ | 74.073 | 83.772▲ |
WILL %R | -85.075▼ | -97.167▼ | -97.207▼ | -50.240 | -24.326▲ |
CCI | -144.135▼ | -85.300 | -90.599 | 22.282 | 86.144 |
Friday, July 11, 2025 12:31 PM
What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market ...
|
Thursday, July 10, 2025 07:24 AM
Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity. Read more here.
|
Thursday, July 10, 2025 05:59 AM
Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. (“Gilead” or the “Company”) (NASDAQ: GILD). Such investors are ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 113.54 | 113.81 | 109.45 | 109.64 | 6,115,100 |
10/07/25 | 113.07 | 114.87 | 112.8301 | 114.54 | 6,096,671 |
09/07/25 | 112.43 | 113.67 | 111.83 | 113.24 | 5,232,144 |
08/07/25 | 111.76 | 113.15 | 110.89 | 111.06 | 4,682,400 |
07/07/25 | 112.00 | 112.58 | 110.75 | 111.78 | 6,949,258 |
03/07/25 | 111.55 | 112.08 | 110.61 | 111.75 | 4,026,397 |
02/07/25 | 111.79 | 112.83 | 111.09 | 111.51 | 5,991,100 |
01/07/25 | 111.50 | 112.57 | 110.80 | 111.73 | 7,675,800 |
30/06/25 | 110.61 | 111.44 | 109.88 | 110.87 | 6,600,400 |
27/06/25 | 108.26 | 112.00 | 106.84 | 110.67 | 19,542,300 |
|
|
||||
|
|
||||
|
|